Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

Vistagen to Present at Stifel 2022 Healthcare Conference


Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that its Chief Executive Officer, Shawn Singh, will present and host one-on-one meetings at the Stifel 2022 Healthcare Conference taking place in New York on November 15 and 16, 2022.

Stifel 2022 Healthcare Conference Details
Presentation Date and Time: Tuesday, November 15, 2022 at 9:10 a.m. Eastern Time
Location: New York, New York

Investors interested in arranging a one-on-one meeting during the conference should contact the Stifel 2022 Healthcare Conference coordinator.

About Vistagen

Vistagen (Nasdaq: VTGN) is a late clinical-stage, CNS-focused biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The Company is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those that are currently available. Vistagen's clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression ? one mind at a time. Connect at www.Vistagen.com.


These press releases may also interest you

at 17:50
Breast Tissue Expander Market size is set to grow by USD 282.4 million from 2024-2028, Increasing prevalence of breast cancer boost the market, Technavio
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:50
Sleep Apnea Implants Market size is set to grow by USD 401.75 thousand from 2024-2028, Increasing prevalence of sleep apnea and respiratory disorders boost the market, Technavio
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

at 17:45
Implantable Medical Devices Market size is set to grow by USD 53.5 billion from 2024-2028, Rise in number of people with chronic illnesses to boost the market growth, Technavio
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

at 17:35
Transplant Box Market size is set to grow by USD 2.39 billion from 2024-2028, Increasing prevalence of chronic disorders boost the market, Technavio
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

at 17:31
BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...

at 17:30
Dermatology Devices Market size is set to grow by USD 154.23 billion from 2024-2028, Increasing prevalence of skin disorders to boost the market growth, Technavio
The global dermatology devices market  size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period.  Increasing prevalence of skin...

More news about Health...


News published on and distributed by: